Home LiteratureArticle Details
PMID: 11881745 Published · ppublish English Journal Article Review

Cholesterol, A beta and Alzheimer's disease.

Trends in neurosciences ·Vol. 24 ·No. 11 Suppl ·2001-11-00 ·Pages S45-8

Hartmann T

Abstract

Statins have been used for many years for the treatment of hypercholesterolemia. They lower low-density lipoprotein (LDL) cholesterol, increase high-density lipoprotein (HDL) levels and are considered to be very safe. Recently, a set of potential new applications was identified for statins. In the future, these drugs could be used to treat Alzheimer's disease (AD). Past studies have suggested a link between AD and lipids and a series of reports has recently been published that significantly tightens this link and also provides some explanations at the cellular level. This review focuses on these recent developments and perspectives that appear to link cholesterol, beta-amyloid and AD.

MeSH Terms
Alzheimer Disease/drug therapy,genetics,metabolism Amyloid beta-Peptides/metabolism Cholesterol/metabolism Humans Hypolipidemic Agents/therapeutic use
Chemicals
Amyloid beta-Peptides Hypolipidemic Agents Cholesterol
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Hartmann T
Center for Molecular Biology Heidelberg (ZMBH), University of Heidelberg, Germany. tobias.hartmann@mail.zmbh.uni-heidelberg.de
Article Info
Journal
Trends in neurosciences
Abbr.
Trends Neurosci
ISSN
0166-2236
Published
2001-11-00
Pages
S45-8
Language
English
Region
England
NLM ID
7808616
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com